Reality will soon come to medical practices specifically geared to individuals based on their genetic makeup. A new report issued by the HHS pinpoints work that lies ahead for the government, biotechnology and pharmaceutical companies, and other stakeholders. The possibility of predicting health, preventing and preempting disease, and personalizing treatment based on an individual’s unique biology will have a profound effect on the healthcare system as a whole.

In a new audio conference from Medical Device Daily, dynamic and experienced speaker Dan Mendelson, of Avalere Health, will discuss trends in personalized medicine and their implications for commercialization strategies for new and emerging therapeutics and medical technologies (biotechnology, med-tech devices, medical imaging and diagnostic testing).

The audio conference, “Personalized Medicine—Transforming Healthcare and Creating Opportunity,” is just $349 per listening site, Nov. 27 from 1 p.m. to 2:30 p.m. It includes presentation handouts and a half-hour Q&A session with the speaker. A CD (MP3 format) of the conference is also available. For more information or to register, please call 800-688-2421 or 404-262-5474, and be sure to mention conference code T07482.